This Week's Chemistry & Life Science Headlines

Andrew M Smith andrew at selectscience.net
Fri Apr 30 08:06:35 EST 1999


This week, www.selectscience.net reported
on 50 news stories the day they happened,
so if you need to keep up to speed on
the latest business developments in
chemistry and life science, make the news
ticker on www.selectscience.net part of
your daily routine.

Andrew Smith (andrew at selectscience.net)
Editor, www.selectscience.net

This week's headlines were:

La Jolla Pharmaceutical Scientists Tolerize B Cells That Thwart
Xenotransplantation

FDA Approves First Home Test for Hepatitis C Virus

Metra Biosystems Reports Third Quarter Results

PE Biosystems Reports Sharply Higher Earnings And Celera Genomics Makes
Progress In Establishing Operations

Thermo Electron and Thermo Power Considering Merger Proposal

Pharmacia & Upjohn Reports First-Quarter Sales And Earnings

Targeted Genetics Reports First Quarter 1999 Financial Results

Genome Therapeutics Strengthens Business Development Team

Aurora Biosciences Reports First Quarter 1999 Financial Results

Dade Behring and HemoSense Agree to Collaborate On New-Generation
Point-of-Care and Home Coagulation Tests

Hyseq Announces First Quarter Financial Results

STERIS Reports Record Fiscal Fourth Quarter and Full Year Results

Perkin-Elmer Shareholders Approve Recapitalization Proposal

Maxygen Obtains Exclusive License to Caltech 'StEP' Directed Evolution
Technology

Steris CFO Resigns

Bio-Rad Reports Results for First Quarter 1999

PPL Therapeutics plc Preliminary Results

European Union to Adopt Common Framework for Electronic Document Signature

Becton Dickinson Announces Planned Acquisition of Clontech Laboratories

Trinity Biotech Announces Record First Quarter Profits; Net Profit up 100%
with 65% Growth in Earnings Per Share

Caliper Technologies CorpLaunches New Manufacturing Facility and Corporate
Headquarters

BIO Strongly Backs U.SSenBennett's Efforts To Protect Patient
Confidentiality

Gel Documentation System Wins UK Design Council Millenium Product Stats

Aronex Pharmaceuticals, IncReports First Quarter 1999 Results

Delsys Pharmaceutical Names Marty Kashef, Ph.D., Director of Engineering
Sciences

Goats Cloned by Tufts University School of Veterinary Medicine and Genzyme
Transgenics Corp

Radiation Missing Cell Nucleus May Still Cause DNA Changes

GlaxoWellcome Wins Queens Award for Technological Achievement

Megabios Acquires Angiogenesis Gene

Pharmacyclics Completes Enrollment in Phase I ANTRIN(TM) Trial For
Atherosclerosis

Beckman Coulter Announces First Quarter 1999 Results

Sarnoff & Mediscience Commercialize Light-Based Molecular Technology For
Cervical Cancer

Caliper Files Suit Against Aclara for Trade Secret Violations

Sequenom Obtains Patents for DNA MassArray Technology

Aclara Biosciences & PE Biosystems Sign Drug Screening Collaboration

Millipore Reports First Quarter Results

CombiChem Appoints Michael GRusnak to the Position of Vice President,
Business Development

TRANSGENE Announces First Quarter Results

Bailey to Head Health Industry Manufacturers Association (HIMA)

AmeriPath, IncAnnounces 1999 First Quarter Results

Coulter Pharmaceutical Reports 1999 First Quarter Financial Results

Abbott Announces Executive Promotions

Genset Reports First Quarter 1999 Financial Results

Genset Reinforces Its Obesity Program with the Creation of a New
Physiological Genomics Department and Publishes First Gene Discovery Results

Mettler-Toledo International IncReports First Quarter 1999 Results

Rohm and Haas Withdraws Tender Offer; Will Acquire Morton through Merger

Progenics Report on Novel HIV Inhibitor is Published in The Journal Of
Virology

Centaur Pharmaceuticals Announces First Quarter 1999 Financial Results

EG&G Announces 24% Increase In Diluted Earnings Per Share For The First
Quarter 1999

Human Genome Sciences Reports First Quarter Financial Results






More information about the Dros mailing list